Praxis Precision Medicines Inc Dividends
The next dividend date for Praxis Precision Medicines Inc has not yet been scheduled.
What is a Dividend Date
When we talk about a dividend date, we’re referring specifically to the ex-dividend date.
This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.
The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.
Most brokerages will automatically credit the dividend to your account once it’s issued.
Historical Dividends for Praxis Precision Medicines Inc (PRAX)
More About Praxis Precision Medicines Inc
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance. The company's platforms include cerebrum, a small molecule platform for CNS small molecule therapies to develop orally available precision therapies; and solidus to discover and develop antisense oligonucleotide. It also develops Ulixacaltamide, a small molecule inhibitor of T-type calcium channels that is in Phase 3 clinical trial for the treatment of essential tremor; Vormatrigine, a small molecule targeting the hyperexcitable state of sodium-channels in the brain to treat focal onset epilepsy; Relutrigine for the treatment of developmental and epileptic encephalopathies; PRAX-020 to treat KCNT1; and PRAX-050. In addition, the company develops Elsunersen, a clinical-stage ASO designed to regulate NaV1.2 expression for the treatment of SCN2A-DEE; PRAX-080 that targets PCDH19-related developmental epilepsy; PRAX-090 for targeting SYNGAP1 loss-of-function; and PRAX-100 that targets SCN2A LoF mutations. It has a license agreement with RogCon Inc.; and research collaboration and license agreement with Ionis Pharmaceuticals, Inc. Praxis Precision Medicines, Inc. was incorporated in 2015 and is based in Boston, Massachusetts.
Owning Praxis Precision Medicines Inc Stock on the Dividend Date
If you own Praxis Precision Medicines Inc stock on the ex-dividend date, then you earn the associated dividend.
Theoretically, the price of Praxis Precision Medicines Inc stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Praxis Precision Medicines Inc stock).
Therefore, it is typically not expected that there is any incremental profit to be gained from buying Praxis Precision Medicines Inc stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Praxis Precision Medicines Inc dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.
Learning More Praxis Precision Medicines Inc Dividends
You can contact us any time if you would like to ask questions about Praxis Precision Medicines Inc dividends or anything else related to the stock market.